Membrane targeting and pore formation by the type III secretion system translocon

FEBS Journal

Volumn 278, Issue 3, 2011, Pages 414-426

  Matteï, Pierre Jean ^a   Faudry, Eric ^b   Job, Viviana ^a   Izoré, Thierry ^a   Attree, Ina ^b   Dessen, Andréa ^a  

^a INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^b CNRS   (France)

Author keywords

bacterial infection; injection; membrane; pore formation; secretion; toxin

Indexed keywords

BACTERIAL ANTIGEN; CHAPERONE; TRANSLOCON; UNCLASSIFIED DRUG; V ANTIGEN;

CELL MEMBRANE; CHANNEL GATING; HYDROPHOBICITY; MEMBRANE COMPONENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TYPE III SECRETION SYSTEM;

BACTERIA (MICROORGANISMS); EUKARYOTA; NEGIBACTERIA;

EID: 78751651347     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07974.x     Document Type: Review

References (119)

1. Cornelis GR, (2006) The type III secretion injectisome. Nat Rev Microbiol 4, 811-825.
2. Galán JE, (2009) Common themes in the design and function of bacterial effectors. Cell Host Microbe 5, 571-579.
3. Marlovits TC, &, Stebbins CE, (2009) Type III secretion systems shape up as they ship out. Curr Opin Microbiol 13, 1-6.
4. Hodgkinson JL, Horsley A, Stabat D, Simon M, Johnson S, da Fonseca PCA, Morris EP, Wall JS, Lea SM, &, Blocker AJ, (2009) Three-dimensional reconstruction of the Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughout. Nat Struct Mol Biol 5, 477-485.
5. Moraes TF, Spreter T, &, Strynadka NCJ, (2008) Piecing together the type III injectisome of bacterial pathogens. Curr Opin Struct Biol 18, 258-266.
6. Schraidt O, Lefebre MD, Brunner MJ, Schmied WH, Schmidt A, Radics J, Mechtler K, Galán JE, &, Marlovits TC, (2010) Topology and organization of the Salmonella typhimurium type III secretion needle complex components. PLoS Pathog 6, e1000824.
7. Spreter T, Yip CK, Sanowar S, Andre I, Kimbrough TG, Vuckovic M, Pfuetzner RA, Deng W, Yu AC, Finlay BB, et al. (2009) A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system. Nat Struct Mol Biol 5, 468-476.
8. Akeda Y, &, Galán JE, (2005) Chaperone release and unfolding of substrates in type III secretion. Nature 437, 911-915.
9. Paul K, Erhardt M, Hirano T, Blair DF, &, Hughes KT, (2008) Energy source of flagellar type III secretion. Nature 451, 489-493.
10. Minamino T, &, Namba K, (2008) Distinct roles of the FliI ATPase and proton motive force in bacterial flagellar protein export. Nature 451, 485-489.
11. Blocker A, Jouihri N, Larquet E, Gounon P, Ebel F, Parsot C, Sansonetti P, &, Allaoui A, (2001) Structure and composition of the Shigella flexneri'needle complex', a part of its type III secreton. Mol Microbiol 39, 652-663.
12. Marlovits TC, Kubori T, Lara-Tejero M, Thomas D, Unger VM, &, Galán JE, (2006) Assembly of the inner rod determines needle length in the type III secretion injectisome. Nature 441, 637-640.
13. Deane JE, Roversi P, Cordes FS, Johnson S, Kenjale R, Daniell S, Booy F, Picking WD, Picking WL, Blocker AJ, et al. (2006) Molecular model of a type III secretion needle: implications for host-cell sensing. Proc Natl Acad Sci USA 103, 12529-12533.
14. 2+ and host cell contact proceeds through two distinct signaling pathways. Infect Immun 74, 3334-3341.
15. Veenendaal AK, Hodgkinson JL, Schwarzer L, Stabat D, Zenk SF, &, Blocker AJ, (2007) The type III secretion system needle tip complex mediates host cell sensing and translocon insertion. Mol Microbiol 63, 1719-1730.
16. Enninga J, Mounier J, Sansonetti P, &, Tran van Nhieu G, (2005) Secretion of type III effectors into host cells in real time. Nat Methods 2, 959-965.
17. Mills E, Baruch K, Charpentier X, Kobi S, &, Rosenshine I, (2008) Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe 3, 104-113.
18. Broz P, Mueller CA, Muller SA, Phlippsen A, Sorg I, Engel A, &, Cornelis GR, (2007) Function and molecular architecture of the Yersinia injectisome tip complex. Mol Microbiol 65, 1311-1320.
19. Goure J, Pastor A, Faudry E, Chabert J, Dessen A, &, Attree I, (2004) The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes. Infect Immun 72, 4741-4750.
20. Lee P-C, Stopford CM, Svenson AG, &, Rietsch A, (2010) Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV. Mol Microbiol 75, 924-941.
21. Mueller CA, Broz P, Muller SA, Ringler P, Erne-Brand F, Sorg I, Kuhn M, Engel A, &, Cornelis GR, (2005) The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310, 674-676.
22. Picking WL, Nishioka H, Hearn PD, Baxter MA, Harrington AT, Blocker A, &, Picking WD, (2005) IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes. Infect Immun 73, 1432-1440.
23. Johnson S, Roversi P, Espina M, Olive A, Deane JE, Birket S, Field T, Picking WD, Blocker AJ, Galyov EE, et al. (2007) Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD. J Biol Chem 282, 4035-4044.
24. Blocker A, Gounon P, Larquet E, Niebuhr K, Cabiaux V, Parsot C, &, Sansonetti P, (1999) The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes. J Cell Biol 147, 683-693.
25. Hakansson S, Schesser K, Persson C, Gaylov EE, Rosqvist R, Homble F, &, Wolf-Watz H, (1996) The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J 15, 5812-5823.
26. Schoehn G, Di Guilmi AM, Lemaire D, Attree I, Weissenhorn W, &, Dessen A, (2003) Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas. EMBO J 22, 4957-4967.
27. Troisfontaines P, &, Cornelis GR, (2005) Type III secretion: more systems than you think. Physiology 20, 326-339.
28. Büttner CR, Sorg I, Cornelis GR, Heinz DW, &, Niemann HH, (2008) Structure of the Yersinia enterocolitica type III secretion translocator chaperone SycD. J Mol Biol 375, 997-1012.
29. Lunelli M, Lokareddy RK, Zychlinksy A, &, Kolbe M, (2009) IpaB-IpgC interaction defines binding motif for type III secretion translocator. Proc Natl Acad Sci USA 106, 9661-9666.
30. Job V, Matteî P-J, Lemaire D, Attree I, &, Dessen A, (2010) Structural basis of chaperone recognition by type III secretion system minor translocator proteins. J Biol Chem 285, 23224-23232.
31. D'Andrea LD, &, Regan L, (2003) TPR proteins: the versatile helix. Trends Biochem Sci 28, 655-662.
32. Quinaud M, Ple S, Job V, Contreras-Martel C, Simorre J-P, Attree I, &, Dessen A, (2007) Structure of the heterotrimeric complex that regulates type III secretion needle formation. Proc Natl Acad Sci USA 104, 7803-7808.
33. Sun P, Tropea JE, Austin BP, Cherry S, &, Waugh DS, (2008) Structural characterization of the Yersinia pesits type III secretion system needle protein YscF in complex with its heterodimeric chaperone YscE/YscG. J Mol Biol 377, 819-830.
34. Plé S, Job V, Dessen A, &, Attree I, (2010) Co-chaperone interactions in export of the type III needle component PscF of Pseudomonas aeruginosa. J Bacteriol 192, 3801-3808.
35. Faudry E, Job V, Dessen A, Attree I, &, Forge V, (2007) Type III secretion system translocator has a molten globule conformation both in its free and chaperone-bound forms. FEBS J 274, 3601-3610.
36. Hamada D, Kato T, Ikegami T, Suzuki KN, Hayashi M, Murooka Y, Honda T, &, Yanagihara I, (2005) EspB from enterohaemorrhagic Escherichia coli is a natively partially folded protein. FEBS J 272, 756-768.
37. Zarivach R, Vuckovic M, Deng W, Finlay BB, &, Strynadka NC, (2007) Structural analysis of a prototypical ATPase from the type III secretion system. Nat Struct Mol Biol 14, 131-137.
38. Imada K, Minamino T, Tahara A, &, Namba K, (2007) Structural similarity between the flagellar type III ATPase FliI and F1-ATPase subunits. Proc Natl Acad Sci USA 104, 485-490.
39. Muller SA, Pozidis C, Stone R, Meesters C, Chami M, Engel A, Economou A, &, Stahlberg H, (2006) Double hexameric ring assembly of the type III protein translocase ATPase HrcN. Mol Microbiol 61, 119-125.
40. Davis AJ, de Jesus Diaz DA, &, Mecsas J, (2010) A dominant-negative needle mutant blocks type III secretion of ealy but not late substrates in Yersinia. Mol Microbiol 76, 236-259.
41. Cooper CA, Zhang K, Andres SN, Fang Y, Kaniuk NA, Hannemann M, Brumell JH, Foster LJ, Junop MS, &, Coombes BK, (2010) Structural and biochemical characterization of SrcA, a multi-cargo type III secretion chaperone in Salmonella required for pathogenic association with a host. PloS Pathog 6, e1000751.
42. Miki T, Shibagaki Y, Danbara H, &, Okada N, (2010) Functional characterization of SsaE, a novel chaperone protein of the type III secretion system encoded by Salmonella pathogenicity island 2. J Bacteriol 191, 6843-6854.
43. McGhie EJ, Hume PJ, Hayward RD, Torres J, &, Koronakis V, (2002) Topology of the Salmonella invasion protein SipB in a model bilayer. Mol Microbiol 44, 1309-1321.
44. Hume PJ, McGhie EJ, Hayward RD, &, Koronakis V, (2003) The purified Shigella IpaB and Salmonella SipB translocators share biochemical properties and membrane topology. Mol Microbiol 49, 425-439.
45. Ryndak MB, Chung H, London E, &, Bliska JB, (2005) Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein. Infect Immun 73, 2433-2443.
46. Schroeder GN, &, Hilbi H, (2007) Cholesterol is required to trigger caspase-1 activation and macrophage apopotosis after phagosomal escape of Shigella. Cell Microbiol 9, 265-278.
47. Hayward RD, McGhie EJ, &, Koronakis V, (2000) Membrane fusion activity of purified SipB, a Salmonella surface protein essential for mammalian cell invasion. Mol Microbiol 37, 727-739.
48. Shaw RK, Daniell S, Ebel F, Frankel G, &, Knutton S, (2001) EspA filament-mediated protein translocation into red blood cells. Cell Microbiol 3, 213-222.
49. Faudry E, Vernier G, Neumann E, Forge V, &, Attree I, (2006) Synergistic pore formation by type III toxin translocators of Pseudomonas aeruginosa. Biochemistry 45, 8117-8123.
50. Bröms JE, Sundin C, Francis MS, &, Forsberg A, (2003) Comparative analysis of type III effector translocation by Yersinia pseudotuberculosis expressing native LcrV or PcrV from Pseudomonas aeruginosa. J Infect Dis 188, 239-249.
51. Hermant D, Ménard R, Arricau N, Parsot C, &, Popoff MY, (1995) Functional conservation of the Salmonella and Shigella effectors of entry into epithelial cells. Mol Microbiol 17, 781-789.
52. Roehrich AD, Martinez-Argudo I, Johnson S, Blocker AJ, &, Veenendaal AK, (2010) The extreme C terminus of Shigella flexneri IpaB is required for regulation of type IIi secretion, needle tip composition, and binding. Infect Immun 78, 1682-1691.
53. Yu X-J, McGourty K, Liu M, Unsworth KE, &, Holden DW, (2010) pH sensing by intracellular Salmonella induces effector translocation. Science 328, 1040-1043.
54. Shen DK, Saurya S, Wagner C, Nishioka H, &, Blocker AJ, (2010) Domains of the Shigella flexneri T3SS IpaB protein involved in secretion regulation. Infect Immun 78, 4999-5010.
55. Osiecki JC, Barker J, Picking WL, Serfis AB, Berring E, Shah S, Harrington A, &, Picking WD, (2001) IpaC from Shigella and SipC from Salmonella possess similar biochemical properties but are functionally distinct. Mol Microbiol 42, 469-481.
56. Harrington AT, Hearn PD, Picking WL, Barker JR, Wessel A, &, Picking WD, (2003) Structural characterization of the N-terminus of IpaC from Shigella flexneri. Infect Immun 71, 1255-1264.
57. Chang J, Myeni SK, Lin TL, Wu CC, Staiger CJ, &, Zhou D, (2007) SipC multimerization promotes actin nucleation and contributes to Salmonella-induced inflammation. Mol Microbiol 66, 1548-1556.
58. Picking WL, Coye L, Osiecki JC, Serfis AB, Schaper E, &, Picking WD, (2001) Identification of functional regions within invasion plasmid antigen C (IpaC) of Shigella flexneri. Mol Microbiol 39, 100-111.
59. Kueltzo LA, Osiecki J, Barker J, Picking WL, Ersoy B, Picking WD, &, Middaugh CR, (2003) Structure-function analysis of invasion plasmid antigen C (IpaC) from Shigella flexneri. J Biol Chem 278, 2792-2798.
60. Costa TRD, Edqvist PJ, Bröms JE, Ahlund MK, Forsberg A, &, Francis MS, (2010) YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis. J Biol Chem 285, 25269-25284.
61. Tengel T, Sethson I, &, Francis MS, (2002) Conformational analysis by CD and NMR spectroscopy of a peptide encompassing the amphipathic domain of YopD from Yersinia. Eur J Biochem 269, 3659-3668.
62. Nichols CD, &, Casanova JE, (2010) Salmonella-directed recruitment of new membreane to invasion foci via the host exocyst complex. Curr Biol 20, 1316-1320.
63. Kuwae A, Yoshida S, Tamano K, Mimuro H, Suzuki T, &, Sasakawa C, (2001) Shigella invasion of macrophage requires the insertion of IpaC into the host plasma membrane. J Biol Chem 34, 32230-32239.
64. Mounier J, Popoff MR, Enninga J, Frame MC, Sansonetti PJ, &, Tran Van Nhieu G, (2009) The IpaC carboxyterminal effector domain mediates Src-dependent actin polymerization during Shigella invasion of epithelial cells. PLoS Pathog 5, e1000271.
65. Kodama T, Akeda Y, Kono G, Takahashi A, Imura K, Iida T, &, Honda T, (2002) The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with α-catenin. Cell Microbiol 4, 213-222.
66. Hamaguchi M, Hamada D, Suzuki KN, Sakata I, &, Yanagihara I, (2008) Molecular basis of actin reorganization promoted by binding of enterohaemorrhagic Escherichia coli EspB to alpha-catenin. FEBS J 275, 6260-6267.
67. Iizumi Y, Sagara H, Kabe Y, Azuma M, Kume K, Ogawa M, Nagai T, Gillespie PG, Sasakawa C, &, Handa H, (2007) The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe 2, 383-392.
68. Jamouillé V, Francetic O, Sansonetti PJ, &, Tran Van Nhieu G, (2008) Cytoplasmic targeting of IpaC to the bacterial pole directs polar type II secretion in Shigella. EMBO J 27, 447-457.
69. Ide T, Laarman S, Greune L, Schillers H, Oberleithner H, &, Schmidt MA, (2001) Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell Microbiol 3, 669-679.
70. Neyt C, &, Cornelis GR, (1999) Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG. Mol Microbiol 33, 971-981.
71. Dacheux D, Goure J, Chabert J, Usson Y, &, Attree I, (2001) Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol Microbiol 40, 76-85.
72. Cordes FS, Komoriya K, Larquet E, Yang S, Egelman EH, Blocker A, &, Lea SM, (2003) Helical structure of the needle of the type III secretion system of Shigella flexneri. J Biol Chem 278, 17103-17107.
73. Bacon GA, &, Burrows TW, (1956) The basis of virulence in Pasteurella pestis: an antigen determining virulence. Br J Exp Pathol 37, 481-493.
74. Anderson GW Jr, Leary SE, Williamson ED, Titball RW, Welkos SL, Worsham PL, &, Friedlander AM, (1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect Immun 64, 4580-4585.
75. Sawa T, Yahr TL, Ohara M, Kurahashi K, Gropper MA, Wiener-Kronish JP, &, Frank DW, (1999) Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 5, 392-398.
76. Une T, &, Brubaker RR, (1984) Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol 133, 2226-2230.
77. Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, &, Lu S, (2004) A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine 22, 3348-3357.
78. DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, &, Schneewind O, (2006) Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 74, 4910-4914.
79. Espina M, Olive AJ, Kenjale R, Moore DS, Ausar SF, Kaminski RW, Oaks EV, Middaugh CR, Picking WD, &, Picking WL, (2006) IpaD localizes to the tip of the type III secretion needle of Shigella flexneri. Infect Immun 74, 4391-4400.
80. Sani M, Botteaux A, Parsot C, Sansonetti P, Boekema EJ, &, Allaoui A, (2007) IpaD is localized at the tip of the Shigella flexneri type III secretion apparatus. Biochim Biophys Acta 1770, 307-311. (Pubitemid 44969955)
81. Knutton S, Rosenshine I, Pallen MJ, Nisan I, Neves BC, Bain C, Wolff C, Dougan G, &, Frankel G, (1998) A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J 17, 2166-2176.
82. Yip CK, Finlay BB, &, Strynadka NC, (2005) Structural characterization of a type III secretion system filament protein in complex with its chaperone. Nat Struct Mol Biol 12, 75-81.
83. Matson JS, &, Nilles ML, (2001) LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis. J Bacteriol 183, 5082-5091.
84. Matson JS, &, Nilles ML, (2002) Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface. BMC Microbiol 2, 16.
85. Allmond LR, Karaca TJ, Nguyen VN, Nguyen T, Wiener-Kronish JP, &, Sawa T, (2003) Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system. Infect Immun 71, 2230-2233.
86. Sundin C, Thelaus J, Broms JE, &, Forsberg A, (2004) Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN. Microb Pathog 37, 313-322.
87. Nanao M, Ricard-Blum S, Di Guilmi AM, Lemaire D, Lascoux D, Chabert J, Attree I, &, Dessen A, (2003) Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1: 1 complex through high affinity interactions. BMC Microbiol 3, 21.
88. Nakajima R, &, Brubaker RR, (1993) Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 61, 23-31.
89. Nedialkov YA, Motin VL, &, Brubaker RR, (1997) Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect Immun 65, 1196-1203.
90. Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning CJ, Aepfelbacher M, &, Heesemann J, (2002) Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 196, 1017-1024.
91. Gendrin C, Sarrazzin S, Bonnaffé D, Jault J-M, Lortat-Jacob H, &, Dessen A, (2010) Hijacking of the pleiotropic cytokine interferon-γ by the type III secretion system of Yersinia pestis. PLoS ONE 5, e15242.
92. Welkos S, Friedlander A, McDowell D, Weeks J, &, Tobery S, (1998) V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microb Pathog 24, 185-196.
93. Sing A, Roggenkamp A, Geiger AM, &, Heesemann J, (2002) Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol 168, 1315-1321.
94. Ménard R, Sansonetti P, Parsot C, &, Vasselon T, (1994) Extracellular association and cytoplasmic partitioning of the IpaB and IpaC invasins of S. flexneri. Cell 79, 515-525.
95. Pettersson J, Holmstrom A, Hill J, Leary S, Frithz-Lindsten E, von Euler-Matell A, Carlsson E, Titball R, Forsberg A, &, Wolf-Watz H, (1999) The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 32, 961-976.
96. Watarai M, Tobe T, Yoshikawa M, &, Sasakawa C, (1995) Disulfide oxidoreductase activity of Shigella flexneri is required for release of Ipa proteins and invasion of epithelial cells. Proc Natl Acad Sci USA 92, 4927-4931.
97. West NP, Sansonetti P, Mounier J, Exley RM, Parsot C, Guadagnini S, Prevost MC, Prochnicka-Chalufour A, Delepierre M, Tanguy M, et al. (2005) Optimization of virulence functions through glucosylation of Shigella LPS. Science 307, 1313-1317.
98. Olive AJ, Kenjale R, Espina M, Moore DS, Picking WL, &, Picking WD, (2007) Bile salts stimulate recruitment of IpaB to the Shigella flexneri surface, where it colocalizes with IpaD at the tip of the type III secretion needle. Infect Immun 75, 2626-2629.
99. Derewenda U, Mateja A, Devedjiev Y, Routzahn KM, Evdokimov AG, Derewenda ZS, &, Waugh DS, (2004) The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure 12, 301-306.
100. Gebus C, Faudry E, Bohn YS, Elsen S, &, Attree I, (2008) Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis. J Biol Chem 283, 23940-23949.
101. Chen LM, Kaniga K, &, Galan JE, (1996) Salmonella spp. are cytotoxic for cultured macrophages. Mol Microbiol 21, 1101-1015.
102. Holmstrom A, Olsson J, Cherepanov P, Maier E, Nordfelth R, Pettersson J, Benz R, Wolf-Watz H, &, Forsberg A, (2001) LcrV is a channel size-determining component of the Yop effector translocon of Yersinia. Mol Microbiol 39, 620-632.
103. Lee VT, Tam C, &, Schneewind O, (2000) LcrV, a substrate for Yersinia enterocolitica type III secretion, is required for toxin targeting into the cytosol of HeLa cells. J Biol Chem 275, 36869-36875.
104. de Geyter C, Wattiez R, Sansonetti P, Falmagne P, Ruysschaert JM, Parsot C, &, Cabiaux V, (2000) Characterization of the interaction of IpaB and IpaD, proteins required for entry of Shigella flexneri into epithelial cells, with a lipid membrane. Eur J Biochem 267, 5769-5776.
105. Goure J, Broz P, Attree O, Cornelis GR, &, Attree I, (2005) Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J Infect Dis 192, 218-225.
106. Mueller CA, Broz P, &, Cornelis GR, (2008) The type III secretion system tip complex and translocon. Mol Microbiol 68, 1085-1095.
107. Allen-Vercoe E, Waddell B, Livingstone S, Deans J, &, DeVinney R, (2006) Enteropathogenic Escherichia coli Tir translocation and pedestal formation requires membrane cholesterol in the absence of bundle-forming pili. Cell Microbiol 8, 613-624.
108. Hayward RD, Cain RJ, McGhie EJ, Phillips N, Garner MJ, &, Koronakis V, (2005) Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol Microbiol 56, 590-603.
109. van der Goot FG, Tran van Nhieu G, Allaoui A, Sansonetti P, &, Lafont F, (2004) Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism. J Biol Chem 46, 47792-47798.
110. Skoudy A, Mounier J, Aruffo A, Ohayon H, Gounon P, Sansonetti P, &, Tran van Nhieu G, (2000) CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells. Cell Microbiol 2, 19-33.
111. Lafont F, Tran van Nhieu G, Hanada K, Sansonetti P, &, van der Goot FG, (2002) Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO J 21, 4449-4457.
112. Stenrud KF, Adam PR, La Mar CD, Olive AJ, Lushington GH, Sudharsan R, Shelton NL, Givens RS, Picking WL, &, Picking WD, (2008) Deoxycholate interacts with IpaD of Shigella flexneri in inducing the recruitment of IpaB to the type III secretion apparatus needle tip. J Biol Chem 283, 18646-18654.
113. Auerbuch V, Golenbock DT, &, Isberg RR, (2009) Innate immune recognition of Yersinia pseudotuberculosis type III secretion. PLoS Pathog 5, e1000686.
114. Akira S, Uematsu S, &, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
115. Viboud GI, &, Bliska JB, (2001) A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes. EMBO J 20, 5373-5382.
116. Bridge DR, Novotny MJ, Moore ER, &, Olson JC, (2010) Role of host cell polarity and leading edge properties in Pseudomonas type III secretion. Microbiology 156, 356-373.
117. Katayama H, Wang J, Tama F, Chollet L, Gogol EP, Collier RJ, &, Fisher MT, (2010) Three-dimensional structure of the anthrax toxin pore inserted into lipid nanodiscs and lipid vesicles. Proc Natl Acad Sci USA 107, 3453-3457.
118. Johansson LC, Wöhri AB, Katona G, Engström S, &, Neutze R, (2009) Membrane protein crystallization from lipidic phases. Curr Opin Struct Biol 19, 372-378.
119. Bartesaghi A, &, Subramaniam S, (2009) Membrane protein structure determination using cryo-electron tomography and 3D image averaging. Curr Opin Struct Biol 19, 402-407.